As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Due to the widespread use of plasma therapy in the treatment of COVID-19 affected patients, the apheresis industry is expected to benefit from the COVID-19 pandemic. The apheresis industry is expected to grow in the forecast period owing to the widespread use of apheresis units in the care of COVID-19 patients and rising FDA approvals. The increasing R&D activities by the leading pharmaceutical corporations such as Pfizer Inc. (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) to develop COVID-19 vaccines are also driving the industry growth. In addition to this, the increasing number of lifestyle related diseases and hospitalisation rates, a rise in demand for blood components and associated protection, technical advances in the implementation of modern apheresis techniques, and an increase in reimbursement policies and financing for apheresis procedures are expected to significantly contribute to the apheresis industry growth.
Apheresis is increasingly being used in clinically sick patients as a primary medication or as a supplement to other drugs for a variety of disorders, including thrombotic thrombocytopenic purpura, haemolytic uremic syndrome, opioid toxicity, autoimmune disorder, sepsis, and fulminant hepatic failure. The apheresis industry for haematological disorders is projected to rise in the forecast era, owing to rising haematological incidences and the applications of apheresis as a treatment tool for haematological disorders. In recent years, novel therapeutic apheresis options such as immunoadsorption, double filtration, and cytapheresis have been available for the treatment of both primary and secondary autoimmune renal diseases. The involvement of most of the major players in the area, as well as increasing product approvals, play a key role in the market's development. Fresenius SE & Co. KGaA (ETR: FRE), a healthcare company based in Germany invested € 30 million in a project for transfusion and apheresis disposables in the Dominican Republic. Such developments have significantly contributed to the industry growth.
Market Analysis by Product, Technology, Procedure, Application, and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global apheresis market are Nikkiso Co., Ltd., Asahi Kasei Medical Co. Ltd, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Terumo Bct, Inc, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.